This is the authors' abstract. We don't add key points for this paper.
. We infer that these factors contribute to treatment resistance of DIAP cells. These findings provide opportunities to develop novel DH/DE-DLBCL therapies, specifically targeting DIAP cells. KEY POINTS: ● MYC mediated upregulation of TPX2, KPNA2 and RanGAP1 dysregulate the spindle assembly checkpoint in drug-induced polyploid cells.● Drug-induced polyploid cells re-enter the cell cycle via multipolar mitosis, fission or budding, a mechanism of disease relapse.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Islam et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: